Literature DB >> 16284489

Hepatic cirrhosis caused by low-dose oral amiodarone therapy.

Srinivas R Puli1, Matthew A Fraley, Vanaja Puli, Aaron B Kuperman, Martin A Alpert.   

Abstract

A 63-year-old man presented with ascites after therapy with amiodarone, 200 mg orally once per day for 22.5 months. A liver biopsy showed grade 3 chronic hepatitis and micronodular cirrhosis. The presence of striking microvesicular steatosis on light microscopy and lysosomal inclusion bodies on electron microscopy suggested amiodarone hepatotoxicity. This is the first reported case of amiodarone-induced hepatic cirrhosis associated with chronic treatment with 200 mg orally once per day for less than 2 years.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16284489     DOI: 10.1097/00000441-200511000-00012

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  11 in total

1.  High liver density on CT imaging due to amiodarone toxicity.

Authors:  Philipp Pecnik; Verena Ranftl; Martin Windpessl
Journal:  Wien Klin Wochenschr       Date:  2018-02-02       Impact factor: 1.704

2.  Acute hepatitis secondary to parenteral amiodarone does not preclude subsequent oral therapy.

Authors:  Mounia Lahbabi; Nouredine Aqodad; Adil Ibrahimi; Mryem Lahlou; Hafid Aqodad
Journal:  World J Hepatol       Date:  2012-06-27

3.  Analysis of computed tomography density of liver before and after amiodarone administration.

Authors:  Masazumi Matsuda; Aoi Otaka; Tomoki Tozawa; Tomoyuki Asano; Koichi Ishiyama; Manabu Hashimoto
Journal:  Jpn J Radiol       Date:  2018-04-02       Impact factor: 2.374

4.  Amiodarone-induced hepatitis and polyneuropathy.

Authors:  Hyun Mo Kang; Yoon Sae Kang; Seok Hyun Kim; Jae Kyu Seong; Dae Young Kang; Heon Young Lee; Byung Seok Lee
Journal:  Korean J Intern Med       Date:  2007-09       Impact factor: 2.884

Review 5.  Managing atrial fibrillation in the elderly: critical appraisal of dronedarone.

Authors:  Paula Trigo; Gregory W Fischer
Journal:  Clin Interv Aging       Date:  2011-12-30       Impact factor: 4.458

Review 6.  Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease.

Authors:  Liane Rabinowich; Oren Shibolet
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

7.  Amiodarone Alters Cholesterol Biosynthesis through Tissue-Dependent Inhibition of Emopamil Binding Protein and Dehydrocholesterol Reductase 24.

Authors:  Luke B Allen; Thiago C Genaro-Mattos; Allison Anderson; Ned A Porter; Károly Mirnics; Zeljka Korade
Journal:  ACS Chem Neurosci       Date:  2020-04-29       Impact factor: 4.418

8.  Amiodarone-induced cirrhosis of liver: what predicts mortality?

Authors:  Nasir Hussain; Anirban Bhattacharyya; Suartcha Prueksaritanond
Journal:  ISRN Cardiol       Date:  2013-03-14

9.  Amiodarone and risk of liver cirrhosis: a nationwide, population-based study.

Authors:  Ching-Hui Huang; Ya-Yun Lai; Yu-Jui Kuo; Su-Ching Yang; Yu-Jun Chang; Kuo-Kuan Chang; Wen-Kang Chen
Journal:  Ther Clin Risk Manag       Date:  2019-01-10       Impact factor: 2.423

10.  Amiodarone-induced hepatotoxicity - quantitative measurement of iodine density in the liver using dual-energy computed tomography: Three case reports.

Authors:  Hai-Juan Lv; Hong-Wei Zhao
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.